Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
Innovation (Camb)
.
2021 Nov 28;2(4):100165.
doi: 10.1016/j.xinn.2021.100165.
Epub 2021 Sep 8.
Authors
Lei Zhao
1
,
Wu Zhong
1
Affiliation
1
National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
PMID:
34518821
PMCID:
PMC8425668
DOI:
10.1016/j.xinn.2021.100165
No abstract available
Publication types
News